These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 23414291

  • 1. Clinical management of rivaroxaban-treated patients.
    Palareti G, Ageno W, Ferrari A, Filippi A, Imberti D, Pengo V, Rubboli A, Toni D.
    Expert Opin Pharmacother; 2013 Apr; 14(5):655-67. PubMed ID: 23414291
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk.
    Haas S, Bode C, Norrving B, Turpie AG.
    Vasc Health Risk Manag; 2014 Apr; 10():101-14. PubMed ID: 24648742
    [Abstract] [Full Text] [Related]

  • 6. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C, Vedovati MC, Agnelli G.
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical use of new oral anticoagulant drugs: dabigatran and rivaroxaban.
    Baglin T.
    Br J Haematol; 2013 Oct; 163(2):160-7. PubMed ID: 23937286
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
    Morell J, Sullivan B, Khalabuda M, McBride BF.
    J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
    [Abstract] [Full Text] [Related]

  • 15. The use of rivaroxaban for short- and long-term treatment of venous thromboembolism.
    Cohen AT, Dobromirski M.
    Thromb Haemost; 2012 Jun; 107(6):1035-43. PubMed ID: 22371186
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.